Table 1.
Clinical Characteristics of the Study Participants
| ALL participants (n = 473) | Male (n = 173) | Female (n = 300) | P | |
|---|---|---|---|---|
| Age (years) | 39.2 (11.4) | 39.0 (11.5) | 39.4 (11.4) | 0.485 |
| Weight (kg) | 71.1 (14.6) | 72.5 (13.1) | 70.3 (15.4) | 0.055 |
| Height (m) | 1.6 (0.09) | 1.70 (0.07) | 1.61 (0.07) | <0.001 |
| Smoking n (%) | 6 (1.3) | 3 (1.0) | 3 (1.7) | 0.492 |
| Waist circumference (cm) | 87.3 (13.1) | 85.8 (12.7) | 88.1 (13.3) | 0.048 |
| Hip circumference (cm) | 100.9 (12.9) | 97.5 (11.3) | 102.9 (13.4) | <0.001 |
| BMI (kg/m2) | 26.5 (5.3) | 25.1 (4.0) | 27.3 (5.8) | <0.001 |
| WHpR | 0.87 (0.14) | 0.88 (0.09) | 0.86 (0.16) | <0.001 |
| WHtR | 0.53 (0.08) | 0.51 (0.08) | 0.55 (0.08) | <0.001 |
| SBP (mmHg) | 119.3 (18.9) | 119.6 (16.2) | 119.1 (20.3) | 0.276 |
| DBP (mmHg) | 76.4 (13.0) | 76.4 (11.9) | 76.4 (13.6) | 0.875 |
| Fasting glucose (mg%) | 86.4 (27.7) | 87.1 (26.0) | 86.1 (28.7) | 0.267 |
| Triglyceride (mg%) | 123.6 (80.6) | 127.7 (84.1) | 121.2 (78.6) | 0.413 |
| High-density lipoprotein (mg%) | 71.7 (29.0) | 71.7 (26.2) | 71.6 (30.6) | 0.715 |
| TyG index | 8.4 (0.7) | 8.4 (0.7) | 8.3 (0.7) | 0.342 |
| TyG-BMI | 221.7 (51.1) | 210.7 (40.5) | 228.1 (55.4) | 0.001 |
| TyG-WC | 730.5 (134.7) | 722.1 (131.3) | 735.3 (136.6) | 0.311 |
| TyG-WHpR | 7.3 (1.4) | 7.4 (1.0) | 7.2 (1.6) | <0.001 |
| TyG-WHtR | 4.5 (0.8) | 4.3 (0.8) | 4.6 (0.9) | <0.001 |
| MS n (%) | 86 (18.2) | 20 (11.6) | 66 (22.0) | 0.005 |
Data were expressed as n (SD), except for smoking history and MS that were expressed as n (%).
BMI, body mass index; DBP, diastolic blood pressure; MS, metabolic syndrome; SBP, systolic blood pressure; SD, standard deviation; TyG, triglyceride-glucose; TyG-BMI, product of TyG and body mass index; TyG-WC, product of TyG and waist circumference; TyG-WHpR, product of TyG and waist-to-hip ratio; TyG-WHtR, product of TyG and waist-to-height ratio; WHpR, waist-to-hip ratio; WHtR, waist-to height ratio.